Hugging Face's logo

Datasets:
yicozy
/
dataset_study_dictionary

Modalities:
Text
Formats:
parquet
Size:
1K - 10K
Libraries:
Datasets
pandas
Dataset card Viewer Files Community
Dataset Viewer
Auto-converted to Parquet
Full Screen
study_ids
sequence
corpus
string
[ "NCT02195479", "NCT02252172" ]
Transplant Ineligible
[ "NCT02195479", "NCT00114101", "NCT02541383", "NCT02541383", "NCT01660633", "NCT00551928", "NCT00551928", "NCT02874742", "NCT00430365", "NCT02252172", "NCT01554852", "NCT01554852" ]
Newly Diagnosed Multiple Myeloma (NDMM)
[ "NCT02195479", "NCT03180736", "NCT03158688", "NCT02541383", "NCT02541383", "NCT02136134", "NCT03277105", "NCT02874742", "NCT02990338", "NCT03275285", "NCT02252172", "NCT03412565", "NCT02076009", "NCT01985126" ]
Anti-CD38 MAb
[ "NCT02195479", "NCT00103662", "NCT03180736", "NCT02412878", "NCT01080391", "NCT03110562", "NCT00114101", "NCT03158688", "NCT02541383", "NCT02541383", "NCT02136134", "NCT03277105", "NCT04162210", "NCT01239797", "NCT01568866", "NCT00551928", "NCT00551928", "NCT02990338", "NCT00430365", "NCT03275285", "NCT04181827", "NCT03651128", "NCT02252172", "NCT05083169", "NCT01554852", "NCT01554852", "NCT01311687", "NCT03151811", "NCT01734928", "NCT01023308", "NCT02076009", "NCT01712789", "NCT01564537" ]
Phase 3
[ "NCT02195479" ]
Daratumumab+Velcade (Bortezomib) +Melphalan+Prednisone (D-VMP)
[ "NCT02195479" ]
Velcade (Bortezomib) +Melphalan+Prednisone (VMP)
[ "NCT02195479" ]
ALCYONE
[ "NCT02195479", "NCT02252172" ]
Transplant Ineligible, Newly Diagnosed Multiple Myeloma (NDMM)
[ "NCT02195479", "NCT02252172" ]
Transplant Ineligible, Anti-CD38 MAb
[ "NCT02195479", "NCT02252172" ]
Transplant Ineligible, Phase 3
[ "NCT02195479" ]
Transplant Ineligible, Daratumumab+Velcade (Bortezomib) +Melphalan+Prednisone (D-VMP)
[ "NCT02195479" ]
Transplant Ineligible, Velcade (Bortezomib) +Melphalan+Prednisone (VMP)
[ "NCT02195479" ]
Transplant Ineligible, ALCYONE
[ "NCT02195479", "NCT02541383", "NCT02541383", "NCT02874742", "NCT02252172" ]
Newly Diagnosed Multiple Myeloma (NDMM), Anti-CD38 MAb
[ "NCT02195479", "NCT00114101", "NCT02541383", "NCT02541383", "NCT00551928", "NCT00551928", "NCT00430365", "NCT02252172", "NCT01554852", "NCT01554852" ]
Newly Diagnosed Multiple Myeloma (NDMM), Phase 3
[ "NCT02195479" ]
Newly Diagnosed Multiple Myeloma (NDMM), Daratumumab+Velcade (Bortezomib) +Melphalan+Prednisone (D-VMP)
[ "NCT02195479" ]
Newly Diagnosed Multiple Myeloma (NDMM), Velcade (Bortezomib) +Melphalan+Prednisone (VMP)
[ "NCT02195479" ]
Newly Diagnosed Multiple Myeloma (NDMM), ALCYONE
[ "NCT02195479", "NCT03180736", "NCT03158688", "NCT02541383", "NCT02541383", "NCT02136134", "NCT03277105", "NCT02990338", "NCT03275285", "NCT02252172", "NCT02076009" ]
Anti-CD38 MAb, Phase 3
[ "NCT02195479" ]
Anti-CD38 MAb, Daratumumab+Velcade (Bortezomib) +Melphalan+Prednisone (D-VMP)
[ "NCT02195479" ]
Anti-CD38 MAb, Velcade (Bortezomib) +Melphalan+Prednisone (VMP)
[ "NCT02195479" ]
Anti-CD38 MAb, ALCYONE
[ "NCT02195479" ]
Phase 3, Daratumumab+Velcade (Bortezomib) +Melphalan+Prednisone (D-VMP)
[ "NCT02195479" ]
Phase 3, Velcade (Bortezomib) +Melphalan+Prednisone (VMP)
[ "NCT02195479" ]
Phase 3, ALCYONE
[ "NCT02195479" ]
Daratumumab+Velcade (Bortezomib) +Melphalan+Prednisone (D-VMP), Velcade (Bortezomib) +Melphalan+Prednisone (VMP)
[ "NCT02195479" ]
Daratumumab+Velcade (Bortezomib) +Melphalan+Prednisone (D-VMP), ALCYONE
[ "NCT02195479" ]
Velcade (Bortezomib) +Melphalan+Prednisone (VMP), ALCYONE
[ "NCT02195479", "NCT02252172" ]
Transplant Ineligible, Newly Diagnosed Multiple Myeloma (NDMM), Anti-CD38 MAb
[ "NCT02195479", "NCT02252172" ]
Transplant Ineligible, Newly Diagnosed Multiple Myeloma (NDMM), Phase 3
[ "NCT02195479" ]
Transplant Ineligible, Newly Diagnosed Multiple Myeloma (NDMM), Daratumumab+Velcade (Bortezomib) +Melphalan+Prednisone (D-VMP)
[ "NCT02195479" ]
Transplant Ineligible, Newly Diagnosed Multiple Myeloma (NDMM), Velcade (Bortezomib) +Melphalan+Prednisone (VMP)
[ "NCT02195479" ]
Transplant Ineligible, Newly Diagnosed Multiple Myeloma (NDMM), ALCYONE
[ "NCT02195479", "NCT02252172" ]
Transplant Ineligible, Anti-CD38 MAb, Phase 3
[ "NCT02195479" ]
Transplant Ineligible, Anti-CD38 MAb, Daratumumab+Velcade (Bortezomib) +Melphalan+Prednisone (D-VMP)
[ "NCT02195479" ]
Transplant Ineligible, Anti-CD38 MAb, Velcade (Bortezomib) +Melphalan+Prednisone (VMP)
[ "NCT02195479" ]
Transplant Ineligible, Anti-CD38 MAb, ALCYONE
[ "NCT02195479" ]
Transplant Ineligible, Phase 3, Daratumumab+Velcade (Bortezomib) +Melphalan+Prednisone (D-VMP)
[ "NCT02195479" ]
Transplant Ineligible, Phase 3, Velcade (Bortezomib) +Melphalan+Prednisone (VMP)
[ "NCT02195479" ]
Transplant Ineligible, Phase 3, ALCYONE
[ "NCT02195479" ]
Transplant Ineligible, Daratumumab+Velcade (Bortezomib) +Melphalan+Prednisone (D-VMP), Velcade (Bortezomib) +Melphalan+Prednisone (VMP)
[ "NCT02195479" ]
Transplant Ineligible, Daratumumab+Velcade (Bortezomib) +Melphalan+Prednisone (D-VMP), ALCYONE
[ "NCT02195479" ]
Transplant Ineligible, Velcade (Bortezomib) +Melphalan+Prednisone (VMP), ALCYONE
[ "NCT02195479", "NCT02541383", "NCT02541383", "NCT02252172" ]
Newly Diagnosed Multiple Myeloma (NDMM), Anti-CD38 MAb, Phase 3
[ "NCT02195479" ]
Newly Diagnosed Multiple Myeloma (NDMM), Anti-CD38 MAb, Daratumumab+Velcade (Bortezomib) +Melphalan+Prednisone (D-VMP)
[ "NCT02195479" ]
Newly Diagnosed Multiple Myeloma (NDMM), Anti-CD38 MAb, Velcade (Bortezomib) +Melphalan+Prednisone (VMP)
[ "NCT02195479" ]
Newly Diagnosed Multiple Myeloma (NDMM), Anti-CD38 MAb, ALCYONE
[ "NCT02195479" ]
Newly Diagnosed Multiple Myeloma (NDMM), Phase 3, Daratumumab+Velcade (Bortezomib) +Melphalan+Prednisone (D-VMP)
[ "NCT02195479" ]
Newly Diagnosed Multiple Myeloma (NDMM), Phase 3, Velcade (Bortezomib) +Melphalan+Prednisone (VMP)
[ "NCT02195479" ]
Newly Diagnosed Multiple Myeloma (NDMM), Phase 3, ALCYONE
[ "NCT02195479" ]
Newly Diagnosed Multiple Myeloma (NDMM), Daratumumab+Velcade (Bortezomib) +Melphalan+Prednisone (D-VMP), Velcade (Bortezomib) +Melphalan+Prednisone (VMP)
[ "NCT02195479" ]
Newly Diagnosed Multiple Myeloma (NDMM), Daratumumab+Velcade (Bortezomib) +Melphalan+Prednisone (D-VMP), ALCYONE
[ "NCT02195479" ]
Newly Diagnosed Multiple Myeloma (NDMM), Velcade (Bortezomib) +Melphalan+Prednisone (VMP), ALCYONE
[ "NCT02195479" ]
Anti-CD38 MAb, Phase 3, Daratumumab+Velcade (Bortezomib) +Melphalan+Prednisone (D-VMP)
[ "NCT02195479" ]
Anti-CD38 MAb, Phase 3, Velcade (Bortezomib) +Melphalan+Prednisone (VMP)
[ "NCT02195479" ]
Anti-CD38 MAb, Phase 3, ALCYONE
[ "NCT02195479" ]
Anti-CD38 MAb, Daratumumab+Velcade (Bortezomib) +Melphalan+Prednisone (D-VMP), Velcade (Bortezomib) +Melphalan+Prednisone (VMP)
[ "NCT02195479" ]
Anti-CD38 MAb, Daratumumab+Velcade (Bortezomib) +Melphalan+Prednisone (D-VMP), ALCYONE
[ "NCT02195479" ]
Anti-CD38 MAb, Velcade (Bortezomib) +Melphalan+Prednisone (VMP), ALCYONE
[ "NCT02195479" ]
Phase 3, Daratumumab+Velcade (Bortezomib) +Melphalan+Prednisone (D-VMP), Velcade (Bortezomib) +Melphalan+Prednisone (VMP)
[ "NCT02195479" ]
Phase 3, Daratumumab+Velcade (Bortezomib) +Melphalan+Prednisone (D-VMP), ALCYONE
[ "NCT02195479" ]
Phase 3, Velcade (Bortezomib) +Melphalan+Prednisone (VMP), ALCYONE
[ "NCT02195479" ]
Daratumumab+Velcade (Bortezomib) +Melphalan+Prednisone (D-VMP), Velcade (Bortezomib) +Melphalan+Prednisone (VMP), ALCYONE
[ "NCT02195479", "NCT02252172" ]
Transplant Ineligible, Newly Diagnosed Multiple Myeloma (NDMM), Anti-CD38 MAb, Phase 3
[ "NCT02195479" ]
Transplant Ineligible, Newly Diagnosed Multiple Myeloma (NDMM), Anti-CD38 MAb, Daratumumab+Velcade (Bortezomib) +Melphalan+Prednisone (D-VMP)
[ "NCT02195479" ]
Transplant Ineligible, Newly Diagnosed Multiple Myeloma (NDMM), Anti-CD38 MAb, Velcade (Bortezomib) +Melphalan+Prednisone (VMP)
[ "NCT02195479" ]
Transplant Ineligible, Newly Diagnosed Multiple Myeloma (NDMM), Anti-CD38 MAb, ALCYONE
[ "NCT02195479" ]
Transplant Ineligible, Newly Diagnosed Multiple Myeloma (NDMM), Phase 3, Daratumumab+Velcade (Bortezomib) +Melphalan+Prednisone (D-VMP)
[ "NCT02195479" ]
Transplant Ineligible, Newly Diagnosed Multiple Myeloma (NDMM), Phase 3, Velcade (Bortezomib) +Melphalan+Prednisone (VMP)
[ "NCT02195479" ]
Transplant Ineligible, Newly Diagnosed Multiple Myeloma (NDMM), Phase 3, ALCYONE
[ "NCT02195479" ]
Transplant Ineligible, Newly Diagnosed Multiple Myeloma (NDMM), Daratumumab+Velcade (Bortezomib) +Melphalan+Prednisone (D-VMP), Velcade (Bortezomib) +Melphalan+Prednisone (VMP)
[ "NCT02195479" ]
Transplant Ineligible, Newly Diagnosed Multiple Myeloma (NDMM), Daratumumab+Velcade (Bortezomib) +Melphalan+Prednisone (D-VMP), ALCYONE
[ "NCT02195479" ]
Transplant Ineligible, Newly Diagnosed Multiple Myeloma (NDMM), Velcade (Bortezomib) +Melphalan+Prednisone (VMP), ALCYONE
[ "NCT02195479" ]
Transplant Ineligible, Anti-CD38 MAb, Phase 3, Daratumumab+Velcade (Bortezomib) +Melphalan+Prednisone (D-VMP)
[ "NCT02195479" ]
Transplant Ineligible, Anti-CD38 MAb, Phase 3, Velcade (Bortezomib) +Melphalan+Prednisone (VMP)
[ "NCT02195479" ]
Transplant Ineligible, Anti-CD38 MAb, Phase 3, ALCYONE
[ "NCT02195479" ]
Transplant Ineligible, Anti-CD38 MAb, Daratumumab+Velcade (Bortezomib) +Melphalan+Prednisone (D-VMP), Velcade (Bortezomib) +Melphalan+Prednisone (VMP)
[ "NCT02195479" ]
Transplant Ineligible, Anti-CD38 MAb, Daratumumab+Velcade (Bortezomib) +Melphalan+Prednisone (D-VMP), ALCYONE
[ "NCT02195479" ]
Transplant Ineligible, Anti-CD38 MAb, Velcade (Bortezomib) +Melphalan+Prednisone (VMP), ALCYONE
[ "NCT02195479" ]
Transplant Ineligible, Phase 3, Daratumumab+Velcade (Bortezomib) +Melphalan+Prednisone (D-VMP), Velcade (Bortezomib) +Melphalan+Prednisone (VMP)
[ "NCT02195479" ]
Transplant Ineligible, Phase 3, Daratumumab+Velcade (Bortezomib) +Melphalan+Prednisone (D-VMP), ALCYONE
[ "NCT02195479" ]
Transplant Ineligible, Phase 3, Velcade (Bortezomib) +Melphalan+Prednisone (VMP), ALCYONE
[ "NCT02195479" ]
Transplant Ineligible, Daratumumab+Velcade (Bortezomib) +Melphalan+Prednisone (D-VMP), Velcade (Bortezomib) +Melphalan+Prednisone (VMP), ALCYONE
[ "NCT02195479" ]
Newly Diagnosed Multiple Myeloma (NDMM), Anti-CD38 MAb, Phase 3, Daratumumab+Velcade (Bortezomib) +Melphalan+Prednisone (D-VMP)
[ "NCT02195479" ]
Newly Diagnosed Multiple Myeloma (NDMM), Anti-CD38 MAb, Phase 3, Velcade (Bortezomib) +Melphalan+Prednisone (VMP)
[ "NCT02195479" ]
Newly Diagnosed Multiple Myeloma (NDMM), Anti-CD38 MAb, Phase 3, ALCYONE
[ "NCT02195479" ]
Newly Diagnosed Multiple Myeloma (NDMM), Anti-CD38 MAb, Daratumumab+Velcade (Bortezomib) +Melphalan+Prednisone (D-VMP), Velcade (Bortezomib) +Melphalan+Prednisone (VMP)
[ "NCT02195479" ]
Newly Diagnosed Multiple Myeloma (NDMM), Anti-CD38 MAb, Daratumumab+Velcade (Bortezomib) +Melphalan+Prednisone (D-VMP), ALCYONE
[ "NCT02195479" ]
Newly Diagnosed Multiple Myeloma (NDMM), Anti-CD38 MAb, Velcade (Bortezomib) +Melphalan+Prednisone (VMP), ALCYONE
[ "NCT02195479" ]
Newly Diagnosed Multiple Myeloma (NDMM), Phase 3, Daratumumab+Velcade (Bortezomib) +Melphalan+Prednisone (D-VMP), Velcade (Bortezomib) +Melphalan+Prednisone (VMP)
[ "NCT02195479" ]
Newly Diagnosed Multiple Myeloma (NDMM), Phase 3, Daratumumab+Velcade (Bortezomib) +Melphalan+Prednisone (D-VMP), ALCYONE
[ "NCT02195479" ]
Newly Diagnosed Multiple Myeloma (NDMM), Phase 3, Velcade (Bortezomib) +Melphalan+Prednisone (VMP), ALCYONE
[ "NCT02195479" ]
Newly Diagnosed Multiple Myeloma (NDMM), Daratumumab+Velcade (Bortezomib) +Melphalan+Prednisone (D-VMP), Velcade (Bortezomib) +Melphalan+Prednisone (VMP), ALCYONE
[ "NCT02195479" ]
Anti-CD38 MAb, Phase 3, Daratumumab+Velcade (Bortezomib) +Melphalan+Prednisone (D-VMP), Velcade (Bortezomib) +Melphalan+Prednisone (VMP)
[ "NCT02195479" ]
Anti-CD38 MAb, Phase 3, Daratumumab+Velcade (Bortezomib) +Melphalan+Prednisone (D-VMP), ALCYONE
[ "NCT02195479" ]
Anti-CD38 MAb, Phase 3, Velcade (Bortezomib) +Melphalan+Prednisone (VMP), ALCYONE
[ "NCT02195479" ]
Anti-CD38 MAb, Daratumumab+Velcade (Bortezomib) +Melphalan+Prednisone (D-VMP), Velcade (Bortezomib) +Melphalan+Prednisone (VMP), ALCYONE
[ "NCT02195479" ]
Phase 3, Daratumumab+Velcade (Bortezomib) +Melphalan+Prednisone (D-VMP), Velcade (Bortezomib) +Melphalan+Prednisone (VMP), ALCYONE
[ "NCT02195479" ]
Transplant Ineligible, Newly Diagnosed Multiple Myeloma (NDMM), Anti-CD38 MAb, Phase 3, Daratumumab+Velcade (Bortezomib) +Melphalan+Prednisone (D-VMP)
[ "NCT02195479" ]
Transplant Ineligible, Newly Diagnosed Multiple Myeloma (NDMM), Anti-CD38 MAb, Phase 3, Velcade (Bortezomib) +Melphalan+Prednisone (VMP)
End of preview. Expand in Dataset Viewer.

Dataset Card for "dataset_study_dictionary"

More Information needed

Downloads last month
30
Edit dataset card
Size of downloaded dataset files:
118 kB
Size of the auto-converted Parquet files:
118 kB
Number of rows:
7,774